<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report on cell growth, <z:mp ids='MP_0000002'>morphology</z:mp>, and immunocytochemistry of the first human cell line, PC-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, derived from a bone marrow of a patient with therapy-related <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> who had no overt <z:hpo ids='HP_0001909'>leukemia</z:hpo> post-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> phase </plain></SENT>
<SENT sid="1" pm="."><plain>This cell population consisted of fast-growing mononuclear cells </plain></SENT>
<SENT sid="2" pm="."><plain>Standard cytochemistry methods for detection of MPO, <z:chebi fb="23" ids="18059">lipids</z:chebi>, <z:chebi fb="15" ids="28087">glycogen</z:chebi> and ANAE gave results as follows: MPO and SBB negative while <z:chebi fb="61" ids="27565">PAS</z:chebi> and ANAE positive </plain></SENT>
<SENT sid="3" pm="."><plain>Positive cytochemical staining and immunophenotype analyses indicated that PC-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cells have some characteristics of the early myeloid precursor cell </plain></SENT>
<SENT sid="4" pm="."><plain>As the first t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> derived cell line it could be a new tool in evaluation of complex biology of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and also serves as a model for diverse in-vitro research </plain></SENT>
</text></document>